Most regions of the central nervous system (CNS) have a limited capacity for repair, largely due to the inability of damaged axons to grow back to their targets. During development, PSA facilitates this process, and because most regions of the adult CNS no longer express PSA, we are conducting studies to determine if viral delivery of PSA-synthetic capability into regions of nerve damage could facilitate the restoration of connections.